hearing loss

News

Early result backs Regeneron’s deafness gene therapy

Regeneron’s gene therapy for a profound form of deafness affecting children, DB-OTO, has shown the first signs that it can improve hearing in a clinical trial.

News

Regeneron dials up in gene therapy with Decibel deal

Regeneron has agreed a $109 million deal to acquire Decibel Therapeutics and its early-stage gene therapy for a form of congenital deafness, several years after forming a

News

Hearing aids could cut cognitive decline in some patients

With so much attention focused on the use of pricey amyloid-busting therapies for A

News

Sensorion files to start trials of deafness gene therapy

French biotech Sensorion has filed its first regulatory application to start human testing of OTOF-GT, a gene therapy for one of the most common forms of congenital deafne

News

Lilly nabs another gene therapy firm, buying hearing loss pl...

Eli Lilly has agreed to buy hearing loss gene therapy developer Akouos in a deal that could value the company at around $610 million – if its lead candidate progresses as hoped in the clini

News

Otonomy's hearing loss drug shows no benefit in trial, tanki...

Otonomy has chalked up its second clinical trial failure in the space of a few months, the latest in a mid-stage study of a treatment for hearing loss, and the biotech has now been forced i

Early result backs Regeneron’s deafness gene therapy

Regeneron dials up in gene therapy with Decibel deal

Hearing aids could cut cognitive decline in some patients

Sensorion files to start trials of deafness gene therapy

Lilly nabs another gene therapy firm, buying hearing loss pl...

Otonomy's hearing loss drug shows no benefit in trial, tanki...

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

hearing loss

Editor's Picks